3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Colorectal Neoplasms
90
Stomach Neoplasms
44
Pancreatic Neoplasms
37
Rectal Neoplasms
29
Colonic Neoplasms
23
Neoplasms
22
Esophageal Neoplasms
21
Squamous Cell Carcinoma of Head and Neck
20
Neoplasm Metastasis
17
Cholangiocarcinoma
16
Adenocarcinoma Of Esophagus
16
Biliary Tract Neoplasms
13
Parkinson Disease 4, Autosomal Dominant Lewy Body
12
Head and Neck Neoplasms
12
Esophageal Squamous Cell Carcinoma
12
Carcinoma, Non-Small-Cell Lung
12
Adenocarcinoma
12
Urinary Bladder Neoplasms
11
Ovarian Neoplasms
9
Gastrointestinal Neoplasms
8
Carcinoma, Hepatocellular
7
Endometrial Neoplasms
6
Breast Neoplasms
6
Gallbladder Neoplasms
5
Advanced Solid Tumors
5
Uterine Cervical Neoplasms
4
Peritoneal Neoplasms
4
Lung Neoplasms
4
Carcinoma
4
Appendiceal Neoplasms
4
Interventions
pomalidomide
2
liposomal doxorubicin
2
plerixafor
1
abemaciclib
1
Watchful Waiting
1
Vincristine
1
Transurethral Resection of Prostate
1
Self Care
1
Rituximab
1
Proctoscopy
1
Prednisone
1
Paclitaxel
1
Nivolumab
1
Maraviroc
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Focus Groups
1
Fluorouracil
1
Filgrastim
1
Etoposide
1
Doxorubicin
1
Cyclophosphamide
1
Colposcopy
1
Blood Specimen Collection
1
Benzethonium
1
Anti-HIV Agents
1
Amyloid
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acquired Immunodeficiency Syndrome
×
Fluorouracil
×
1 year
×
Clear all
NCT05413811
2026-02-17
ACT2
UNC Lineberger Comprehensive Cancer Center
Phase NA
Completed
180 enrolled